Loey's Dietz syndrome

Jump to navigation Jump to search
Loeys-Dietz syndrome
OMIM below See below
DiseasesDB 34032

WikiDoc Resources for Loey's Dietz syndrome

Articles

Most recent articles on Loey's Dietz syndrome

Most cited articles on Loey's Dietz syndrome

Review articles on Loey's Dietz syndrome

Articles on Loey's Dietz syndrome in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Loey's Dietz syndrome

Images of Loey's Dietz syndrome

Photos of Loey's Dietz syndrome

Podcasts & MP3s on Loey's Dietz syndrome

Videos on Loey's Dietz syndrome

Evidence Based Medicine

Cochrane Collaboration on Loey's Dietz syndrome

Bandolier on Loey's Dietz syndrome

TRIP on Loey's Dietz syndrome

Clinical Trials

Ongoing Trials on Loey's Dietz syndrome at Clinical Trials.gov

Trial results on Loey's Dietz syndrome

Clinical Trials on Loey's Dietz syndrome at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Loey's Dietz syndrome

NICE Guidance on Loey's Dietz syndrome

NHS PRODIGY Guidance

FDA on Loey's Dietz syndrome

CDC on Loey's Dietz syndrome

Books

Books on Loey's Dietz syndrome

News

Loey's Dietz syndrome in the news

Be alerted to news on Loey's Dietz syndrome

News trends on Loey's Dietz syndrome

Commentary

Blogs on Loey's Dietz syndrome

Definitions

Definitions of Loey's Dietz syndrome

Patient Resources / Community

Patient resources on Loey's Dietz syndrome

Discussion groups on Loey's Dietz syndrome

Patient Handouts on Loey's Dietz syndrome

Directions to Hospitals Treating Loey's Dietz syndrome

Risk calculators and risk factors for Loey's Dietz syndrome

Healthcare Provider Resources

Symptoms of Loey's Dietz syndrome

Causes & Risk Factors for Loey's Dietz syndrome

Diagnostic studies for Loey's Dietz syndrome

Treatment of Loey's Dietz syndrome

Continuing Medical Education (CME)

CME Programs on Loey's Dietz syndrome

International

Loey's Dietz syndrome en Espanol

Loey's Dietz syndrome en Francais

Business

Loey's Dietz syndrome in the Marketplace

Patents on Loey's Dietz syndrome

Experimental / Informatics

List of terms related to Loey's Dietz syndrome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: LDS

Overview

Loeys-Dietz syndrome is a recently-discovered autosomal dominant genetic syndrome which has many features similar to Marfan syndrome, but which is caused by mutations in the genes encoding transforming growth factor beta receptor 1 (TGFBR1) or 2 (TGFBR2).[1][2][3]

Historical Perspective

It was identified and characterized by American physician Harry C. Dietz and Belgian physician Bart L. Loeys, for whom it is named.

Classification

There are currently two forms of Loeys-Dietz syndrome which are further subdivided into another two forms based upon the genetic abnormality as shown in the table below:

Type Gene Locus OMIM Description
1A TGFBR1 9q22 609192 Also known as Furlong disease
1B TGFBR2 3p22 610168
2A TGFBR1 9q22 608967
2B TGFBR2 3p22 610380 Previously known as Marfan syndrome type 2

Pathophysiology

Associated Conditions

Differentiating Loey's Dietz Syndrome from other Disorders

Many of the physical findings typical in Loeys-Dietz syndrome are also found in Marfan syndrome cases, including increased risk of ascending aortic aneurysm and aortic dissection, abnormally long limbs and fingers, and dural ectasia (a gradual stretching and weakening of the dura mater that can cause abdominal and leg pain). However, it also has some additional traits not typical of Marfan patients, including widely spaced eyes, a split uvula in the back of the throat, and skin findings such as easy bruising or abnormal scars.

Diagnosis

Physical Examination

General Appearance

Skin

  • Translucency of the skin with velvety texture

Head

Cardiac

Extremities

Imaging Findings

Aortic and arterial aneurysms/dissections with tortuosity (corkscrew structure) of the arteries.

Treatment

As there is no known cure, Loeys-Dietz syndrome is a lifelong condition. Due to the high risk of death from aortic aneurysm rupture, patients should be followed closely to monitor aneurysm formation, which can then be corrected with vascular surgery.

Previous research in laboratory mice has suggested that the angiotensin II receptor antagonist losartan, which appears to block TGF-beta activity, can slow or halt the formation of aortic aneurysms in Marfan syndrome. A large clinical trial sponsored by the National Institutes of Health is currently underway to explore the use of losartan to prevent aneurysms in Marfan syndrome patients. Both Marfan syndrome and Loeys-Dietz syndrome are associated with increased TGF-beta signaling in the vessel wall. Therefore, losartan also holds promise for the treatment of Loeys-Dietz syndrome.

See also

References

  1. Loeys BL, Schwarze U, Holm T; et al. (2006). "Aneurysm syndromes caused by mutations in the TGF-beta receptor". N. Engl. J. Med. 355 (8): 788–98. doi:10.1056/NEJMoa055695. PMID 16928994.
  2. LeMaire SA, Pannu H, Tran-Fadulu V, Carter SA, Coselli JS, Milewicz DM (2007). "Severe aortic and arterial aneurysms associated with a TGFBR2 mutation". Nature clinical practice. Cardiovascular medicine. 4 (3): 167–71. doi:10.1038/ncpcardio0797. PMC 2561071. PMID 17330129.
  3. Loeys BL, Chen J, Neptune ER; et al. (2005). "A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2". Nat. Genet. 37 (3): 275–81. doi:10.1038/ng1511. PMID 15731757. Unknown parameter |month= ignored (help)

External links

Categor:Cariology id:Sindrom Loeys-Dietz

References